Canadian Observational Study Evaluating the Long-term IMPACT of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators on People With CF

RecruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Cystic Fibrosis

Interventions

DRUG

Trikafta

Highly Effective CFTR Modulator Therapy

Trial Locations (2)

RECRUITING

British Columbia Children's Hospital, Vancouver

RECRUITING

St Paul's Hospital, Vancouver

All Listed Sponsors

lead

University of British Columbia

OTHER